nach oben

Erschienen in:

01.12.2015 | Original Article

Effects of ovarian dopaminergic receptors on ovulation

verfasst von: Berenice Venegas-Meneses, José Francisco Padilla, Claudia Elvira Juárez, José Luis Morán, Carolina Morán, Nora Hilda Rosas-Murrieta, Anabella Handal, Roberto Domínguez

Erschienen in: Endocrine | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Hormonal and neural signals regulate the ovarian follicular development. The present study’s hypothesis is that the blockade of ovarian dopamine receptors locally will affect follicle development and ovulation. Groups of adult 4-day cyclic rats of the CII-ZV strain on estrus, diestrus-1, diestrus-2, or proestrus day were injected with vehicle, haloperidol (DA2 > DA1 blocker), sulpiride (DA2 blocker), or SCH-23390 (DA1 blocker) into the bursa of both ovaries at 08:00, 13:00, or 20:00 h. Animals were sacrificed the following predicted estrus day. The following treatments blocked ovulation: injecting haloperidol to rats on estrus or diestrus-1 at 8:00, 13:00, or 20:00 h and to rats on diestrus-2 at 08:00, or 20:00 h; injecting SCH-23390 to rats on diestrus-1 at 8:00, 13:00, or 20:00 h; injecting sulpiride to rats on estrus at 20:00 h, diestrus-1 at 08:00, 13:00, or 20:00 h and to rats on diestrus-2 at 08:00 h. In rats treated with any of the dopamine antagonists that blocked ovulation, injecting GnRH at 14.00 h on the next predicted proestrus day restored ovulation. Injecting estradiol benzoate at 14.00 h of the next predicted diestrus-2 restored ovulation in some animals treated with haloperidol on estrus or diestrus-2 and was ineffective in rats treated on diestrus-1. In rats treated with sulpiride or SCH-23390 ovulation occurred in most animals (SCH-23390: 6/8; SPD: 9/12). Present results suggest that dopamine ovarian receptors’ participation in regulating follicular development and ovulation varies along the estrus cycle, with their most prominent activity occurring on diestrus-1.

L.I. Aguado, Role of the central and peripheral nervous system in the ovarian function. Microsc. Res. Tech. 59(6), 462–473 (2002). doi:10.1002/jemt.10232 CrossRefPubMed

I. Gerendai, P. Banczerowski, B. Halasz, Functional significance of the innervation of the gonads. Endocrine 28(3), 309–318 (2005). doi:10.1385/ENDO:28:3:309 CrossRefPubMed

A. Mayerhofer, H.C. Hemmings Jr, G.L. Snyder, P. Greengard, S. Boddien, U. Berg, C. Brucker, Functional dopamine-1 receptors and DARPP-32 are expressed in human ovary and granulosa luteal cells in vitro. J. Clin. Endocrinol. Metab. 84(1), 257–264 (1999). doi:10.1210/jcem.84.1.5378 PubMed

A. Mayerhofer, G.D. Smith, M. Danilchik, J.E. Levine, D.P. Wolf, G.A. Dissen, S.R. Ojeda, Oocytes are a source of catecholamines in the primate ovary: evidence for a cell-cell regulatory loop. Proc. Natl. Acad. Sci. USA 95(18), 10990–10995 (1998)PubMedCentralCrossRefPubMed

H. D’Albora, J.J. Barcia, Intrinsic neuronal cell bodies in the rat ovary. Neurosci. Lett. 205(1), 65–67 (1996)CrossRefPubMed

W.L. Dees, J.K. Hiney, T.D. Schultea, A. Mayerhofer, M. Danilchik, G.A. Dissen, S.R. Ojeda, The primate ovary contains a population of catecholaminergic neuron-like cells expressing nerve growth factor receptors. Endocrinology 136(12), 5760–5768 (1995). doi:10.1210/endo.136.12.7588334 PubMed

H. D’Albora, P. Lombide, S.R. Ojeda, Intrinsic neurons in the rat ovary: an immunohistochemical study. Cell Tissue Res. 300(1), 47–56 (2000)CrossRefPubMed

P.G. Hofmann, A. Baez Saldana, T. Fortoul Van Der Goes, M. Gonzalez del Pliego, G. Gutierrez Ospina, Neuroendocrine cells are present in the domestic fowl ovary. J. Anat. 222(2), 170–177 (2013). doi:10.1111/joa.12002 PubMedCentralCrossRefPubMed

J.M. Bahr, N. Ben-Jonathan, Preovulatory depletion of ovarian catecholamines in the rat. Endocrinology 108(5), 1815–1820 (1981). doi:10.1210/endo-108-5-1815 CrossRefPubMed

10.

P.A. Denning-Kendall, M.L. Wild, D.C. Wathes, Regional differences in catecholamine concentrations in bovine ovaries analysed by high-performance liquid chromatography. J. Endocrinol. 129(2), 221–226 (1991)CrossRefPubMed

11.

A. Mayerhofer, S. Fritz, R. Grunert, S.L. Sanders, D.M. Duffy, S.R. Ojeda, R.L. Stouffer, D1-Receptor, DARPP-32, and PP-1 in the primate corpus luteum and luteinized granulosa cells: evidence for phosphorylation of DARPP-32 by dopamine and human chorionic gonadotropin. J. Clin. Endocrinol. Metab. 85(12), 4750–4757 (2000). doi:10.1210/jcem.85.12.7084 CrossRefPubMed

12.

S.S. King, A.G. Campbell, E.A. Dille, J.F. Roser, L.L. Murphy, K.L. Jones, Dopamine receptors in equine ovarian tissues. Domest. Anim. Endocrinol. 28(4), 405–415 (2005). doi:10.1016/j.domaniend.2005.02.001 CrossRefPubMed

13.

S.S. King, K.L. Jones, B.A. Mullenix, D.T. Heath, Seasonal relationships between dopamine D1 and D2 receptor and equine FSH receptor mRNA in equine ovarian epithelium. Anim. Reprod. Sci. 108(1–2), 259–266 (2008). doi:10.1016/j.anireprosci.2007.08.007 CrossRefPubMed

14.

V. Rey-Ares, N. Lazarov, D. Berg, U. Berg, L. Kunz, A. Mayerhofer, Dopamine receptor repertoire of human granulosa cells. Reprod. Biol. Endocrinol. 5, 40 (2007). doi:10.1186/1477-7827-5-40 PubMedCentralCrossRefPubMed

15.

R. Dominguez, C.M. Gaitan, S.A. Mendez, A. Ulloa-Aguirre, Effects of catecholaminergic blockade by haloperidol or propranolol at different stages of the oestrous cycle on ovulation and gonadotrophin levels in the rat. J. Endocrinol. 113(1), 37–44 (1987)CrossRefPubMed

16.

R. Dominguez, D. Zipitría, L. Riboni, R. Revilla, Differences in the ability of reserpine and chlorpromazine to block ovulation throughout the estrous cycle of the rat. J. Interdiscip. Cycle Res. 16(1), 63–72 (1985). doi:10.1080/09291018509359872 CrossRef

17.

S. Isobe, The role of the dopaminergic system in the rat ovary. Nihon Naibunpi Gakkai Zasshi 70(4), 457–464 (1994)PubMed

18.

H. Mori, S. Arakawa, T. Ohkawa, R. Ohkawa, S. Takada, T. Morita, S. Okinaga, The involvement of dopamine in the regulation of steroidogenesis in rat ovarian cells. Horm. Res. 41(Suppl 1), 36–40 (1994)CrossRefPubMed

19.

J. Bodis, M. Koppan, L. Kornya, H.R. Tinneberg, A. Torok, The effect of catecholamines, acetylcholine and histamine on progesterone release by human granulosa cells in a granulosa cell superfusion system. Gynecol. Endocrinol. 16(4), 259–264 (2002)CrossRefPubMed

20.

F. Papenfuss, J. Bodis, H.R. Tinneberg, H. Schwarz, The modulatory effect of catecholamines on gonadotropin-stimulated granulosa cell steroid secretion. Arch. Gynecol. Obstet. 253(2), 97–102 (1993)CrossRefPubMed

21.

M.L. Rankin, L.A. Hazelwood, R. Benjamin Freer, Y. Namkung, B.E. Rex, R.A. Roof, D.R. Sibley, Molecular pharmacology of the dopamine receptors, in Dopamine handbook, vol. 1, ed. by L.L. Iversen, D.S. Iversen, S.B. Dunnett, A. Bjorklund (Oxford University Press, New York, 2010), pp. 63–87

22.

G. Emilien, J.M. Maloteaux, M. Geurts, K. Hoogenberg, S. Cragg, Dopamine receptors: physiological understanding to therapeutic intervention potential. Pharmacol. Ther. 84(2), 133–156 (1999)CrossRefPubMed

23.

C. Moran, A. Franco, J.L. Moran, A. Handal, L. Morales, R. Dominguez, Neural activity between ovaries and the prevertebral celiac-superior mesenteric ganglia varies during the estrous cycle of the rat. Endocrine 26(2), 147–152 (2005). doi:10.1385/endo:26:2:147 CrossRefPubMed

24.

C. Moran, F. Zarate, J.L. Moran, A. Handal, R. Dominguez, Lateralization of the connections of the ovary to the celiac ganglia in juvenile rats. Reprod. Biol. Endocrinol. 7, 50 (2009). doi:10.1186/1477-7827-7-50 PubMedCentralCrossRefPubMed

25.

G. Rosas, M.I. Ramirez, R. Linares, A. Trujillo, R. Dominguez, L. Morales-Ledesma, Asymmetric steroidogenic response by the ovaries to the vasoactive intestinal peptide. Endocrine 48(3), 968–977 (2015). doi:10.1007/s12020-014-0449-x CrossRefPubMed

26.

J.L. Moran, M.E. Cruz, R. Dominquez, Differences in the ovulatory response to unilateral lesions in the preoptic or anterior hypothalamic area performed on each day of the estrous cycle of adult rats. Brain Res. Bull. 33(6), 663–668 (1994)CrossRefPubMed

27.

J.L. Moran, R. Dominguez, Effects of the unilateral implant of haloperidol at the preoptic-anterior hypothalamic area, on ovulation. Endocrine 3(6), 391–393 (1995). doi:10.1007/bf02935642 CrossRefPubMed

28.

R.F. Weick, E.R. Smith, R. Dominguez, A.P. Dhariwal, J.M. Davidson, Mechanism of stimulatory feedback effect of estradiol benzoate on the pituitary. Endocrinology 88(2), 293–301 (1971). doi:10.1210/endo-88-2-293 CrossRefPubMed

29.

A. Díaz, L. De Jesús, L. Mendieta, M. Calvillo, B. Espinosa, E. Zenteno, J. Guevara, I.D. Limón, The amyloid-β25–35 injection into the CA1 region of the neonatal rat hippocampus impairs the long-term memory because of an increase of nitric oxide. Neurosci. Lett. 468(2), 151–155 (2010). doi:10.1016/j.neulet.2009.10.087 CrossRefPubMed

30.

C.A. Schneider, W.S. Rasband, K.W. Eliceiri, NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9(7), 671–675 (2012)CrossRefPubMed

31.

F.X. Donadeu, O.J. Ginther, Follicular waves and circulating concentrations of gonadotrophins, inhibin and oestradiol during the anovulatory season in mares. Reprod. (Camb. Engl.) 124(6), 875–885 (2002)CrossRef

32.

G. Mari, M. Morganti, B. Merlo, C. Castagnetti, F. Parmeggiani, N. Govoni, G. Galeati, C. Tamanini, Administration of sulpiride or domperidone for advancing the first ovulation in deep anestrous mares. Theriogenology 71(6), 959–965 (2009). doi:10.1016/j.theriogenology.2008.11.001 CrossRefPubMed

33.

L. Zoldag, S. Fekete, I. Csaky, A. Bersenyi, Fertile estrus induced in bitches by bromocryptine, a dopamine agonist: a clinical trial. Theriogenology 55(8), 1657–1666 (2001)CrossRefPubMed

34.

M.J. Fell, J.C. Neill, K.M. Marshall, Effects of the classical antipsychotic haloperidol and atypical antipsychotic risperidone on weight gain, the oestrous cycle and uterine weight in female rats. Eur. Neuropsychopharmcol. 14(5), 385–392 (2004). doi:10.1016/j.euroneuro.2003.12.001 CrossRef

35.

K. Maeda, S. Ohkura, Y. Uenoyama, Y. Wakabayashi, Y. Oka, H. Tsukamura, H. Okamura, Neurobiological mechanisms underlying GnRH pulse generation by the hypothalamus. Brain Res. 1364, 103–115 (2010). doi:10.1016/j.brainres.2010.10.026 CrossRefPubMed

36.

N.P. Evans, G.E. Dahl, D.T. Mauger, V. Padmanabhan, L.A. Thrun, F.J. Karsch, Does estradiol induce the preovulatory gonadotropin-releasing hormone (GnRH) surge in the ewe by inducing a progressive change in the mode of operation of the GnRH neurosecretory system. Endocrinology 136(12), 5511–5519 (1995). doi:10.1210/endo.136.12.7588302 PubMed

37.

M.E. Freeman, Chapter 43: neuroendocrine control of the ovarian cycle of the rat, in Knobil and Neill’s physiology of reproduction, 3rd edn., ed. by J.D. Neill, T.M. Plant, D.W. Pfaff, J.R.G. Challis, DMd Kretser, J.S. Richards, P.M. Wassarman (Academic Press, St Louis, 2006), pp. 2327–2388CrossRef

38.

N.P. Evans, G.E. Dahl, V. Padmanabhan, L.A. Thrun, F.J. Karsch, Estradiol requirements for induction and maintenance of the gonadotropin-releasing hormone surge: implications for neuroendocrine processing of the estradiol signal. Endocrinology 138(12), 5408–5414 (1997). doi:10.1210/endo.138.12.5558 PubMed

39.

J.W. Everett, Central neural control of reproductive functions of the adenohypophysis. Physiol. Rev. 44(3), 373–431 (1964)PubMed

40.

T. Baptista, E. Araujo de Baptista, N.M. Ying Kin, S. Beaulieu, D. Walker, R. Joober, J. Lalonde, D. Richard, Comparative effects of the antipsychotics sulpiride or risperidone in rats I: bodyweight, food intake, body composition, hormones and glucose tolerance. Brain Res. 957(1), 144–151 (2002)CrossRefPubMed

41.

B.J. Kinon, J.A. Gilmore, H. Liu, U.M. Halbreich, Hyperprolactinemia in response to antipsychotic drugs: characterization across comparative clinical trials. Psychoneuroendocrinology 28(Suppl 2), 69–82 (2003)CrossRefPubMed

42.

M. Goiny, S. Cekan, K. Uvnas-Moberg, Effects of dopaminergic drugs on plasma levels of steroid hormones in conscious dogs. Life Sci. 38(25), 2293–2300 (1986)CrossRefPubMed

43.

L.A. Arbogast, N. Ben-Jonathan, The preovulatory prolactin surge is prolonged by a progesterone-dependent dopaminergic mechanism. Endocrinology 126(1), 246–252 (1990). doi:10.1210/endo-126-1-246 CrossRefPubMed

44.

Y. Taketa, M. Yoshida, K. Inoue, M. Takahashi, Y. Sakamoto, G. Watanabe, K. Taya, J. Yamate, A. Nishikawa, Differential stimulation pathways of progesterone secretion from newly formed corpora lutea in rats treated with ethylene glycol monomethyl ether, sulpiride, or atrazine. Toxicol. Sci. 121(2), 267–278 (2011). doi:10.1093/toxsci/kfr062 CrossRefPubMed

45.

S. Mostafapour, S. Zare, R.A. Sadrkhanlou, A. Ahmadi, M. Razi, Sulpiride-induced hyperprolactinemia in mature female rats: evidence for alterations in the reproductive system, pituitary and ovarian hormones. Int. J. Fertil. Steril. 8(2), 193–206 (2014)PubMedCentralPubMed

46.

G. Macchiarelli, S.A. Nottola, M.G. Palmerini, S. Bianchi, M. Maione, C. Lorenzo, G. Stifano, E. Di Marco, S. Correr, Morphological expression of angiogenesis in the mammalian ovary as seen by SEM of corrosion casts. Italian J. Anat. Embryol. 115(1–2), 109–114 (2010)

47.

F. Delgado-Rosas, R. Gomez, H. Ferrero, F. Gaytan, J. Garcia-Velasco, C. Simon, A. Pellicer, The effects of ergot and non-ergot-derived dopamine agonists in an experimental mouse model of endometriosis. Reprod. (Camb. Engl.) 142(5), 745–755 (2011). doi:10.1530/rep-11-0223 CrossRef

48.

R. Gomez, H. Ferrero, F. Delgado-Rosas, M. Gaytan, C. Morales, R.C. Zimmermann, C. Simon, F. Gaytan, A. Pellicer, Evidences for the existence of a low dopaminergic tone in polycystic ovarian syndrome: implications for OHSS development and treatment. J. Clin. Endocrinol. Metab. 96(8), 2484–2492 (2011). doi:10.1210/jc.2011-0075 CrossRefPubMed

49.

R. Gomez, M. Gonzalez-Izquierdo, R.C. Zimmermann, E. Novella-Maestre, I. Alonso-Muriel, J. Sanchez-Criado, J. Remohi, C. Simon, A. Pellicer, Low-dose dopamine agonist administration blocks vascular endothelial growth factor (VEGF)-mediated vascular hyperpermeability without altering VEGF receptor 2-dependent luteal angiogenesis in a rat ovarian hyperstimulation model. Endocrinology 147(11), 5400–5411 (2006). doi:10.1210/en.2006-0657 CrossRefPubMed

50.

C.C. Ouimet, P.E. Miller, H.C. Hemmings Jr, S.I. Walaas, P. Greengard, DARPP-32, a dopamine- and adenosine 3′:5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization. J. Neurosci. 4(1), 111–124 (1984)PubMed

Titel: Effects of ovarian dopaminergic receptors on ovulation
verfasst von: Berenice Venegas-Meneses
José Francisco Padilla
Claudia Elvira Juárez
José Luis Morán
Carolina Morán
Nora Hilda Rosas-Murrieta
Anabella Handal
Roberto Domínguez
Publikationsdatum: 01.12.2015
Verlag: Springer US
Erschienen in: Endocrine / Ausgabe 3/2015
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-015-0636-4

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

19.04.2024 | Vorhofflimmern | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Effects of ovarian dopaminergic receptors on ovulation

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Denken Sie bei starker Blutung auch an die Hemmkörper-Hämophilie

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2015

Comparisons of the efficacy of glucose control, lipid profile, and β-cell function between DPP-4 inhibitors and AGI treatment in type 2 diabetes patients: a meta-analysis

The possible role of CD4+CD25highFoxp3+/CD4+IL-17A+ cell imbalance in the autoimmunity of patients with Hashimoto thyroiditis

Pioglitazone in adult rats reverses immediate postnatal overfeeding-induced metabolic, hormonal, and inflammatory alterations

Characteristics of patients with late manifestation of resistance thyroid hormone syndrome: a single-center experience

Effects of soy phytoestrogens on pituitary-ovarian function in middle-aged female rats

Variability in laboratory parameters used for management of Cushing’s syndrome

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Denken Sie bei starker Blutung auch an die Hemmkörper-Hämophilie

Update Innere Medizin